Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs Levetiracetam in Pediatric Epilepsy
NCT02201251Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2014
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of topiramate in epilepsy, sponsored by Janssen Pharmaceutical. Started Oct 2014; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02201251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201251.